SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-10-041932
Filing Date
2010-08-04
Accepted
2010-08-04 17:12:16
Documents
10
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a10-12639_110q.htm 10-Q 986989
2 EX-10.4 a10-12639_1ex10d4.htm EX-10.4 122605
3 EX-10.49 a10-12639_1ex10d49.htm EX-10.49 31922
4 EX-10.50 a10-12639_1ex10d50.htm EX-10.50 96958
5 EX-10.51 a10-12639_1ex10d51.htm EX-10.51 182442
6 EX-31.1 a10-12639_1ex31d1.htm EX-31.1 13033
7 EX-31.2 a10-12639_1ex31d2.htm EX-31.2 13784
8 EX-32 a10-12639_1ex32.htm EX-32 11533
9 GRAPHIC g126391koi001.jpg GRAPHIC 3838
10 GRAPHIC g126391kq01i001.jpg GRAPHIC 3838
  Complete submission text file 0001104659-10-041932.txt   1471638
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 10991844
SIC: 2834 Pharmaceutical Preparations